⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
Cystic Fibrosis Therapeutics Market Set to Reach USD 35.09 Billion by 2033 as Precision CFTR Modulator Therapies Transform Patient Outcomes
prnewswire.com
VRTX
RHHBY
NVS
TEVA
GILD
ALK appoints Edward Jordan as new EVP and head of Commercial Operations North America
globenewswire.com
DBVT
MRK
TEVA
Medincell Management to Present at the 8 th Annual Evercore Healthcare Conference and at the Piper Sandler 37 th Annual Healthcare Conference
businesswire.com
TEVA
Inhaled Therapy in Respiratory Disease Market to Grow USD 16.22 Billion by 2034
globenewswire.com
GSK
AZN
TEVA
BMY
Metered Dose Inhalers Market to Reach $18.4 billion, Globally, by 2034 at 6.2% CAGR: Allied Market Research
prnewswire.com
TEVA
AZN
VTRS
New Interact × Ragan Research Reveals Only 1% of Company Communicators Reach Frontline Workers Effectively
globenewswire.com
LEVI
DPZ
TEVA
SWY
Using Antibiotics Wisely. Making Them Responsibly.
accessnewswire.com
TEVA
Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight
globenewswire.com
GSK
TREVI
MRK
AZN
SNY
TEVA
JNJ
PFE
BMY
LLY
VRTX
AMGN
ABBV
GILD
BIIB
CSL
Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®
globenewswire.com
TEVA
AMGN
Medincell Awarded New Grant to Fight Malaria
businesswire.com
TEVA